Together with Member States and the European Medicines Agency, the Commission has also set-up an executive steering group to monitor potential shortages of medicines due to COVID-19.
Komisjon on loonud koos liikmesriikide ja Euroopa Ravimiametiga juhtrühma, et jälgida COVID-19st tulenevat võimalikku raviminappust.